| 中山醫學大學 |
2016 |
Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan
|
Chen, Chen C.-Y.;Chen, Chen C.-H.;Shen, T.-C.;Cheng, W.-C.;Hsu, C.-N.;Liao, C.-H.;Chen, Chen C.-Y.;Hsia, T.-C.;Liao, W.-C.;Tu, C.-Y.;Shih, C.-M.;Hsu, W.-H. |
| 國立成功大學 |
2020 |
Lung cancer survival and mortality in Taiwan following the initial launch of targeted therapies: An interrupted time series study
|
Hsu, J.C.;Wei, C.-F.;Yang, S.-C.;Lin, P.-C.;Lee, Y.-C.;Lu, C.Y. |
| 中國醫藥大學 |
2009-09 |
Lung cancer susceptibility and genetic polymorphism of DNA repair gene XRCC4 in Taiwan
|
許南榮(Nan-Yung Hsu); 王惠暢(Hwei-Chung Wang); 王仲興(Chung-Hsing Wang); (Chia-Lin Chang); 邱昌芳(Chang-Fang Chiu); 李鳳琴(Hong-Zin Lee); 蔡佳紋(Chia-Wen Tsai); 包大 (Da-Tian Bau)* |
| 亞洲大學 |
2009-02 |
Lung Cancer Susceptibility and Genetic Polymorphisms of Exo1 Gene in Taiwan
|
Hsu, NY (Hsu, Nan-Yung); Wang, HC (Wang, Hwei-Chung); Wang, CH (Wang, Chung-Hsing); Chiu, CF (Chiu, Chang-Fang); Tseng, HC (Tseng, Hsien-Chang); Liang, SY (Liang, Shiu-Yun); Tsai, CW (Tsai, Chia-Wen); Lin, CC (Lin, Cheng-Chieh); Bau, DT (Bau, Da-Tian) |
| 中國醫藥大學 |
2009-02 |
Lung Cancer Susceptibility and Genetic Polymorphisms of EXO1 Gene in Taiwan
|
許南榮(Nan-Yung Hsu);王惠暢(Hwei-Chung Wang);王仲興(Chung-Hsing Wang);邱昌芳(Chang-Fang Chiu);曾憲彰(Hsien-Chang Tseng);梁雲(Shiu-Yun Liang);蔡佳紋(Chia-Wen Tsai);林正介(Cheng-Chieh Lin);包大靝(Da-Tian Bau)* |
| 國立成功大學 |
2009-07-01 |
Lung Cancer Susceptibility and Prognosis Associated With Polymorphisms in the Nonhomologous End-joining Pathway Genes
|
Tseng, Ruo-Chia; Hsieh, Feng-Jen; Shih, Chuen-Ming; Hsu, Han-Shui; Chen, Chih-Yi; Wang, Yi-Ching |
| 中國醫藥大學 |
2009-06 |
Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study
|
曾若嘉(RUo-Chia Tseng); (Feng-Jen Hsieh); 施純明(Chuen-Ming Shih); (Han-Sui Hus); 陳志毅(Chih-Yi Chen); 王憶卿(Yi-Ching Wang)* |
| 臺大學術典藏 |
2020-08-12T08:25:31Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu J.-Y.; SHANG-GIN WU; Yang C.-H.; Gow C.-H.; Chang Y.-L.; Yu C.-J.; Shin J.-Y.; Yang P.-C. |
| 臺大學術典藏 |
2020-12-02T02:34:34Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu J.-Y.;Wu S.-G.;Yang C.-H.;Gow C.-H.;Chang Y.-L.;Yu C.-J.;Shin J.-Y.;Pan-Chyr Yang; Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; Chang Y.-L.; Yu C.-J.; Shin J.-Y.; PAN-CHYR YANG |
| 臺大學術典藏 |
2022-06-27T07:06:21Z |
Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response
|
Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; Chang Y.-L.; CHONG-JEN YU; Shin J.-Y.; Yang P.-C. |
